ClinicalTrials.gg
RecruitingNCT05661097Updated Sep 1, 2023

Clinical Study of Hernia Ring Closure Method in Laparoscopic Abdominal Wall Hernia Repair

An interventional study of Suture mode in Abdominal Wall Hernia, sponsored by Bo Li. Recruiting at 1 site in China. Per ClinicalTrials.gov, last updated 2023-09-01.

Sponsored by Bo Li · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2025, 1 year 10 months ago, but the record still lists the study as recruiting.
  • Started Mar 2023; still recruiting 3 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Sex
All
01

Study summary

By comparing the time of closing the hernia ring, the degree of pain, and the recovery of gastrointestinal tract in different groups Intervening, infection, recurrence and medical cost, to find out whether patients with abdominal wall hernia have different hernias It is the best way to close the hernia ring under laparoscopy and provide evidence based medicine. with In the research process of the research group, a database on abdominal wall hernia will be established for the future Further study of hernia has laid a solid foundation.

02

Conditions studied

  • Abdominal Wall Hernia

Browse trials for

03

In context

Hernia, Abdominal

82 studies on the registry are indexed under Hernia, Abdominal; 19 are open to participants now.

This study's planned enrollment of 100 is above the median of 90 across 48 interventional studies indexed under Hernia, Abdominal.

Browse Hernia, Abdominal studies →

Lead sponsor

This is the only study on the registry with Bo Li as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Conform to the diagnostic criteria of abdominal wall hernia;

    • Patients with general physical condition and can tolerate general anesthesia and laparoscopic surgery; ③ After explaining the situation to the patients and their families, they agreed to join the research group.

Exclusion criteria

Exclusion Criteria:

  • The diagnostic criteria of abdominal wall hernia were not met; ② Patients who have serious medical diseases and cannot tolerate laparoscopic surgery; ③ Patients with mental illness; ④ The judgment is affected by incomplete data.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Small hernia ring group with continuous suture

    Continuous suture of hernia ring with barbed wire\<3cm

    Procedure: Suture mode

  • Active comparator
    Small hernia ring group with discontinuous full-thickness suture

    Intermittent full layer suture to close hernia rings\<3cm

    Procedure: Suture mode

  • Active comparator
    Large hernia ring group with continuous suture

    Continuous suture of hernia ring with barbed wire\>3cm

    Procedure: Suture mode

  • Active comparator
    Large hernia ring group with discontinuous full-thickness suture

    Intermittent full layer suture to close hernia rings\>3cm

    Procedure: Suture mode

  • Experimental
    Large hernia ring group with continuous suture and discontinuous full-thickness suture

    Continuous suture with barbed thread and discontinuous full-thickness suture to close hernia rings\>3cm

    Procedure: Suture mode

Interventions

  • ProcedureSuture mode

    Patients in the small hernia ring group received continuous suture with barbed wire according to simple random method Closure mode, intermittent full layer suture by hernia hook needle.Patients in the large hernia ring group received continuous suture with barbed wire according to simple random method Closure mode, intermittent full layer suture with hernia hook needle, continuous suture with barbed wire+hernia Intermittent full layer crochet suture.

06

What researchers measure

Primary outcomes

  1. recrudescence

    Whether abdominal wall hernia recurred within 24 months

    Time frame: 24 months after operation

Secondary outcomes

  1. Time to close the hernia ring

    Time to close the hernia ring during operation

    Time frame: during operation

  2. Bleeding volume

    Intraoperative bleeding

    Time frame: during operation

  3. Pain level

    Postoperative pain level

    Time frame: immediately after the surgery

  4. Gastrointestinal recovery time

    Postoperative gastrointestinal recovery time

    Time frame: immediately after the surgery

  5. Seroma

    Whether there is seroma after operation

    Time frame: immediately after the surgery

  6. Infected

    Postoperative infection

    Time frame: immediately after the surgery

07

Study locations

1 of 1 sites recruiting
  • The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfo Mountain Hospital)
    Jinan, Shandong 250000, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Jan 2025, 22 months after the start.

Of 31 interventional studies with no phase under Hernia, Abdominal, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 60. This study's planned 22 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 7, 2022
First posted
Dec 22, 2022
StartActual
Mar 1, 2023
Primary completionEst.
Jan 1, 2025
CompletionEst.
Jan 1, 2026
Last update
Sep 1, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 1, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05661097
Lead sponsor
Bo Li
Responsible party
Bo Li (Chief physician, Qianfoshan Hospital) — Sponsor-investigator
First posted
Dec 22, 2022
Start date
Mar 1, 2023
Primary completion
Jan 1, 2025 (estimated)
Completion
Jan 1, 2026 (estimated)
Last update
Sep 1, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion